We use genomics and machine learning to detect residual solid tumor.

Residual Disease

Residual disease is cancer that remains after a treatment.

Patients with liquid tumors have benefited from a series of technical revolutions in residual disease detection. 

But patients with solid tumors like breast cancer have been left behind. Until now. 


About Us

We're a group of careful scientists, quietly working behind the scenes to arm those clinicians on the front lines of cancer care.


Culture of Innovation

Life-changing advances require an environment that nurtures unorthodox ideas while simultaneously rewarding methodical product development.

We strive to work along both ends of the innovation spectrum.

Supported by MBC Biolabs